Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
Wall Street
Price Targets
CLVLY Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
CLVLY
is 18.92 USD
with a low forecast of 10.15 USD and a high forecast of 32.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLVLY's stock price target?
Price Target
18.92
USD
According to Wall Street analysts, the average 1-year price target for
CLVLY
is 18.92 USD
with a low forecast of 10.15 USD and a high forecast of 32.1 USD.
What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
15%
For the last 14 years the
compound annual growth rate for
Clinuvel Pharmaceuticals Ltd's revenue is
31%.
The projected
CAGR
for the next 3 years is
15%.
What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of
Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is
13%.
What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
17%
The
compound annual growth rate
of
Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is
17%.